Spectrum Biomedical

Spectrum Biomedical is a biopharmaceutical company focused on the research, development, and distribution of medical cannabis products. Operating as a subsidiary of Canopy Growth Corporation under the global brand Spectrum Therapeutics, the company is a leader in the standardization of cannabinoid-based medicines. It is recognized for its proprietary color-coded categorization system, which simplifies product selection for healthcare professionals and patients based on specific THC and CBD concentrations. Spectrum Biomedical maintains a clinical pipeline investigating the efficacy of cannabinoids for indications such as chronic pain, anxiety, and sleep disorders, with all products manufactured under strict Good Manufacturing Practice (GMP) standards.